Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...
A Western-led interdisciplinary research team is using artificial intelligence (AI) to target a potentially harmful enzyme found in the human body ...
Health and Me on MSN
Common Blood Pressure Drug Hydralazine Could Slow Down Cancer
Scientists accidentally discovered that a common blood pressure drug called hydralazine could actually slow down fast-growing ...
Sometimes big breakthroughs in science come from very small changes, curiosity, and more than a little luck. A new study from ...
The Healthy @Reader's Digest on MSN
New UPenn Study: A Popular Blood Pressure Drug Could Also Slow This Aggressive Cancer
A long-trusted blood pressure medication could also show some effect to stop the growth of tumors, found a highly trained ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...
VANCOUVER, BC / ACCESS Newswire / November 18, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it is initi ...
For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...
One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, ...
Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback